Testing effectiveness (Phase 2)Study completedNCT00946270What this trial is testingPomalidomide for Myelofibrosis PatientsWho this might be right forPolycythemia VeraThrombocythemia M.D. Anderson Cancer Center 70
Early research (Phase 1)Study completedNCT00910728What this trial is testingStudy to Assess the Safety of AZD1480 in Patients With Myeloproliferative DiseasesWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythaemia VeraEssential Thrombocythaemia Myelofibrosis AstraZeneca 65
Not applicableStudy completedNCT02953704What this trial is testingMyelofibrosis and Essential Thrombocythemia Observational Study (MOST)Who this might be right forMPN (Myeloproliferative Neoplasms) Incyte Corporation 1,469
Early research (Phase 1)Active Not RecruitingNCT04041050What this trial is testingA Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmWho this might be right forMyeloproliferative Neoplasm AbbVie 85
Not applicableLooking for participantsNCT04645199What this trial is testingNational Longitudinal Cohort of Hematological DiseasesWho this might be right forMultiple MyelomaAcute Myeloid LeukemiaHemophilia+14 more Institute of Hematology & Blood Diseases Hospital, China 2,300
Large-scale testing (Phase 3)Study completedNCT01969838What this trial is testingMomelotinib Versus Ruxolitinib in Subjects With MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis Sierra Oncology LLC - a GSK company 432
Not applicableLooking for participantsNCT07590986What this trial is testingIdentification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative NeoplasmWho this might be right forMyeloproliferative Neoplasm (MPN)Polycytemia VeraEssential Thrombocythemia (ET)+1 more Université Catholique de Louvain 150
Large-scale testing (Phase 3)Study completedNCT04173494What this trial is testingMomelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)Who this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis Sierra Oncology LLC - a GSK company 195
Not applicableStudy completedNCT03212053What this trial is testingProspective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)Who this might be right forThrombocythemia Essential Hospices Civils de Lyon 51
Not applicableLooking for participantsNCT06734637What this trial is testingEfficacy and Safety of Peginterferon in ET and PV.Who this might be right forEssential ThrombocythemiaPolycythemia Vera Zhenya Hong 40
Testing effectiveness (Phase 2)UnknownNCT04878003What this trial is testingStudy of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythemia Vera Myelofibrosis (Post-PV-MF)Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF) Kartos Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT05835466What this trial is testingReparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Who this might be right forMyelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF) Icahn School of Medicine at Mount Sinai 10
Not applicableUnknownNCT05921838What this trial is testingThe Role of Circ0014614 in the Formation and Development of ETWho this might be right forPrimary Thrombocytosis Nanfang Hospital, Southern Medical University 120
Early research (Phase 1)Ended earlyNCT01291784What this trial is testingAnti-TGF-beta Therapy in Patients With MyelofibrosisWho this might be right forMyelofibrosisPrimary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+1 more John Mascarenhas 3
Testing effectiveness (Phase 2)UnknownNCT01298934What this trial is testingLBH589 (Panobinostat) for the Treatment of MyelofibrosisWho this might be right forPrimary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis Ronald Hoffman 22
Large-scale testing (Phase 3)UnknownNCT03662126What this trial is testingKRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor TreatmentWho this might be right forPrimary Myelofibrosis (PMF)Post-Polycythemia Vera MF (Post-PV-MF)Post-Essential Thrombocythemia MF (Post-ET-MF) Kartos Therapeutics, Inc. 385
Not applicableStudy completedNCT02893410What this trial is testingDrug Observance and Side Effects of Cytoreductive Drugs in PV and ET PatientsWho this might be right forPolycythemia VeraEssential Thrombocythemia University Hospital, Brest 286
Large-scale testing (Phase 3)Ended earlyNCT03755518What this trial is testingA Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With RuxolitinibWho this might be right forPrimary MyelofibrosisPost-Polycythemia Vera MyelofibrosisMyelofibrosis+1 more Celgene 38
Not applicableStudy completedNCT01816256What this trial is testingScreening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative NeoplasmsWho this might be right forMyeloproliferative Neoplasms (MPN)Polycythemia Vera (PV)Essential Thrombocythemia (ET)+1 more University Health Network, Toronto 102
Not applicableActive Not RecruitingNCT06798805What this trial is testingUnraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative NeoplasmsWho this might be right forEssential Thrombocythemia (ET)Myelofibrosis (MF)Polycythemia Vera (PV) IRCCS Azienda Ospedaliero-Universitaria di Bologna 110